Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVT-15652 (Clotic) in otomycosis
NCT03686397Phase 3Completed
- Sponsor
- Laboratorios Salvat
- Start
- Jun 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in otomycosis comparing SVT-15652 with Placebo (2 arms). Primary endpoint: Therapeutic Cure (Clinical and Mycological Cure) at Day 24. Started Jun 2020; status: completed.
02
Drugs
Clotic
03
Conditions
otomycosis
Beyond the preview
Go deeper on NCT03686397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03686397.